Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas
| Autor: | Vanessa L. Jacoby, Shira Varon, L. Elaine Waetjen, Kathleen Dunn, Ram Parvataneni |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Leiomyosarcoma
medicine.medical_specialty 030219 obstetrics & reproductive medicine Hysterectomy Modalities Radiofrequency ablation business.industry medicine.medical_treatment Obstetrics and Gynecology medicine.disease law.invention Food and drug administration 03 medical and health sciences 0302 clinical medicine Uterine artery embolization Refractory law 030220 oncology & carcinogenesis medicine Radiology Epithelioid leiomyosarcoma business |
| Zdroj: | Journal of Minimally Invasive Gynecology. 26:564-566 |
| ISSN: | 1553-4650 |
| Popis: | Minimally invasive therapies to treat symptoms of uterine myomas can be effective alternatives to major surgery. Such modalities include pharmacologic agents, uterine artery embolization, magnetic resonance-guided focused ultrasound, and laparoscopic radiofrequency ablation, known as the Acessa procedure. Acessa is used to treat women with symptomatic myomas and was approved by the US Food and Drug Administration in 2012. This case describes a patient who underwent Acessa and subsequently required hysterectomy for refractory symptoms. Pathology of her tumor was initially classified as epithelioid leiomyosarcoma but on subsequent review was classified as benign. This report highlights the challenges of accurate histologic diagnosis in the setting of using new therapeutic modalities. Clinicians should report such interventions to pathologists at the time of surgery to allow for accurate diagnosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|